The risk of fatty liver disease is especially high in patients with multiple cardiometabolic risk factors who undergo gallbladder removal, according to research from South Korea.

HCC is the most common type of liver cancer, and it typically occurs in patients with chronic liver conditions. | Image Credit: Crystal light - stock.adobe.com

TACE Plus SBRT Effective in Large Tumors Caused by HCC

By Jared Kaltwasser

July 30th 2025

TACE combined with SBRT enhanced survival rates in patients with large hepatocellular carcinoma tumors, offering promising treatment insights.

Person holding abdomen | Image credit: Satjawat – stock.adobe.com

Dietary Inflammatory Index Not Linked to Liver Fibrosis or Fatty Liver Index in MASLD

By Hayden E. Klein

July 10th 2025

Findings underscore the potential limitations of using systemic inflammatory indices like the Dietary Inflammatory Index and Systemic Immune-Inflammation Index to assess organ-specific conditions.

Surgeons performing bariatric surgery on patient | Image credit: Vadim – stock.adobe.com

Surgeries and Endoscopic Procedures Offer Different Benefits for MASLD

By Hayden E. Klein

July 1st 2025

Researchers said longitudinal studies are critical to refine and optimize the management of metabolic dysfunction–associated steatotic liver disease (MASLD).

<1 2

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions